Zoetis ZTS Number of major product lines
Number of major product lines at other companies
Other financials
Where this comes from
Reported directly by Zoetis in its filing.
Tagged under the XBRL concept zts:NumberOfMajorProductLines.
The source filing: Zoetis’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 2:32 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001555280-26-000040
Over the course of our history, we have focused on developing a diverse portfolio of animal health products that deliver solutions across the continuum of care, including medicines, vaccines and diagnostics, complemented by biodevices, genetic tests and a range of services. We typically refer to all products with the same primary active pharmaceutical or biological ingredient(s) as a single product line even if such products include different brands, dosages, formulations or indicated species. For vaccines, we typically consider a group of vaccines as a single product line if they share the same brand. We have approximately 300 comprehensive product lines, including products for both companion animals and livestock, within each of our major product categories.
Item 1. Financial Statements
FAQ
- What is Zoetis's number of major product lines?
- Zoetis (ZTS) reported number of major product lines of $300 in Q2 2026.
- How has Zoetis's number of major product lines changed year-over-year?
- Zoetis's number of major product lines decreased by 0.0% year-over-year, from $300 to $300.
- What does number of major product lines mean?
- Number of major product lines as reported by ZOETIS INC..
Ask your AI about Zoetis's number of major product lines.
Connect your AI assistant and compare it to peers, right in your chat.
